Correction: Anti-TNF treatment blocks the induction of T cell-dependent humoral responses (Annals of the Rheumatic Diseases (2013) 72 (1037-1043) DOI: 10.1136/annrheumdis-2011-201270);Anti-TNF treatment blocks the induction of T cell-dependent humoral responses

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 1037-1043

  Salinas, Gabriela Franco ^a   De Rycke, Leen ^a,b   Barendregt, Barbara ^c   Paramarta, Jacqueline E ^a   Hreggvidstdottir, Hulda ^a   Cantaert, Tineke ^a,d   Van Der Burg, Mirjam ^c   Tak, Paul P ^a,e   Baeten, Dominique ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PLASMA CELL; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

EID: 84877624677     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-201270corr1     Document Type: Erratum

References (39)

1. Tracey D, Klareskog L, Sasso EH, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008;117:244-79.
2. Hess A, Axmann R, Rech J, et al. Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci USA 2011;108:3731-6.
3. Vos AC, Wildenberg ME, Duijvestein M, et al. Anti-tumor necrosis factor-alpha antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 2011;140:221-30.
4. Pasparakis M, Alexopoulou L, Episkopou V, et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centres, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-411. (Pubitemid 26354696)
5. Francosalinas G, Mai HL, Jovanovic V, et al. TNF blockade abrogates the induction of T cell-dependent humoral responses in an allotransplantation model. J Leukoc Biol 2011;90:367-75.
6. DeRycke L, Baeten D, Kruithof E, et al. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 2005;52:2192-201. (Pubitemid 40994342)
7. DeRycke L, Baeten D, Kruithof E, et al. The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 2005;14:931-7. (Pubitemid 43088266)
8. Anolik JH, Ravikumar R, Barnard J, et al. Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centres and follicular dendritic cell networks. J Immunol 2008;180:688-92.
9. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127-37.
10. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
11. Andersen P, Permin H, Andersen V, et al. Deficiency of somatic hypermutation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 2005;105:511-17. (Pubitemid 40070729)
12. Boussiotis VA, Nadler LM, Strominger JL, et al. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA 1994;91:7007-11. (Pubitemid 24226791)
13. Platt AM, Gibson VB, Patakas A, et al. Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells. J Immunol 2010;185:1558-67.
14. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803-11. (Pubitemid 38113736)
15. Miscia S, Marchisio M, Grilli A, et al . Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ 2002;13:13-18. (Pubitemid 34106795)
16. Scheeren FA, Naspetti M, Diehl S, et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 2005;6:303-13. (Pubitemid 41724768)
17. Diehl SA, Schmidlin H, Nagasawa M, et al. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 2008;180:4805-15.
18. Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or "memory" B cells? J Immunol 2007;179:13-19.
19. . Moens L, Wuyts M, Meyts I, et al. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response. J Immunol 2008;181:5306-12.
20. Berkowska MA, Driessen GJ, Bikos V, et al. Human memory B cells originate from three distinct germinal centre-dependent and -independent maturation pathways. Blood 2011;118:1250-8.
21. Crotty S. Follicular helper CD4T cells (TFH). Annu Rev Immunol 2011;29:621-63.
22. Nutt SL, Tarlinton DM. Germinal centre B and follicular helper T cells: siblings, cousins or just good friends? Nat Immunol 2011;12:472-7.
23. Elkayam O, Caspi D, Reitblatt T, et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8. (Pubitemid 38280827)
24. Mease PJ, Ritchlin CT, Martin RW, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-61. (Pubitemid 38879202)
25. Kapetanovic MC, Saxne T, Nilsson JA, et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2007;46:608-11. (Pubitemid 46523304)
26. Kaine JL, Kivitz AJ, Birbara C, et al. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007;34:272-9.
27. Gelinck LB, van der Bijl AE, Visser LG, et al. Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine. Vaccine 2008;26:3528-33.
28. Fiorino G, Peyrin-Biroulet L, Naccarato P, et al. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis 2012;18:1042-7.
29. Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol 2008;20:632-8.
30. Ravikumar R, Owen T, Barnard J, et al. Anti-TNF therapy in RA patients alters Hepatitis B vaccine responses (abstract). American College of Rheumatology Poster Annual Meeting 2006.
31. Montero M, Gonzalez M, Gonzales A. Antibody response to standard Hepatitis B vaccination in patients with Rheumatoid Arthritis and Ankylosing Spondylitis treated with Infliximab (abstract). Arthritis Rheum 2011;63(Supp10):1316.
32. Cantaert T, Kolln J, Timmer T, et al. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J Immunol 2008;181:785-94.
33. Klaasen R, Thurlings RM, Wijbrandts CA, et al. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study. Arthritis Rheum 2009;60:3217-24.
34. Gommerman JL, Mackay F, Donskoy E, et al. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest 2002;110:1359-69. (Pubitemid 35285762)
35. Visvanathan S, Marini JC, Smolen JS, et al. Changes in biomarkers of in flammation and bone turnover and associations with clinical efficacy following in fliximab plus methotrexate therapy in patients with early rheumatoid arthritis. J Rheumatol 2007;34:1465-74. (Pubitemid 47067980)
36. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010;105:148-54.
37. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 2006;65:191-4. (Pubitemid 43131992)
38. Salemi S, Picchianti-Diamanti A, Germano V, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol 2010;134:113-20.
39. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009;104:444-53.